BrainCheck is an innovative, easy-to-use concussion management system. Developed in the neuroscience laboratory of Dr. David Eagleman at Baylor College of Medicine, BrainCheck facilitates collaboration among members of the care team -- increasing safety and awareness -- and gives individuals who have had an injury a better way to track their recovery. BrainCheck can be used to support concussion protocols to comply with legal mandates.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/27/16 | $3,000,000 | Seed |
Brett Giroir | undisclosed |
| 06/02/17 | $1,500,000 | Seed Extension |
True Wealth Ventures | undisclosed |
| 10/09/19 | $8,000,000 | Series A |
Nueterra Capital S3 Ventures Tensility Venture Partners True Wealth Ventures | undisclosed |
| 11/02/21 | $10,000,000 | Series B |
Next Coast Ventures Nueterra Capital S3 Ventures SelectQuote Tensility Venture Partners True Wealth Ventures UPMC Enterprise | undisclosed |
| 03/06/24 | $15,000,000 |
Next Coast Ventures S3 Ventures UPMC Enterprise | undisclosed |
